Status of Management of Surgery in Beijing During COVID-19
A Descriptive Study on the Proper Management of Gastrointestinal Surgeries During the COVID-19 Pandemic, With an Emphasis on the Alteration of Surgical Protocol and Workflow
1 other identifier
observational
500
0 countries
N/A
Brief Summary
This is a multi-centered, retrospective, observational study aimed at observing the current status of the management of gastrointestinal surgery during the COVID-19 pandemic, particularly the changes on surgery protocols and other key aspects of surgical workflow, so as to share experience with colleagues both domestic and abroad.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2020
CompletedStudy Start
First participant enrolled
May 25, 2020
CompletedFirst Posted
Study publicly available on registry
May 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2020
CompletedMay 27, 2020
May 1, 2020
6 days
May 22, 2020
May 22, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
treatment of fevers at arrival
proportion of patients presented with fever, proportion of patients refered to fever clinics, proportion of patients screened for COVID-19, method of screening (CT? nucleated acid test?)
1 day
treatment of post-operative fevers
proportion of patients on whom fever occured, proportion of patients screened for COVID-19, method of screening (CT? nucleated acid test?)
1 day
assorted surgical parameters
Duration of operation (≥180min/\<180min); Intra-operative transfusion (Y/N); Surgical approach (Laparoscopy-involved/Open); Resection range (Non-radical/Radical); Lymph node dissection (Unknown/Not dissected/D1/D2 or above); Combined organ resection (Y/N); Post-operative complications (Y/N); Post-operative transfusion (Y/N); Post-operative hospital stay (≥7d/\<7d)
1 day
Secondary Outcomes (1)
hospitals' protection measures and extent of implementation
1 month
Study Arms (2)
patients treated at surgical emergency rooms
patients receiving surgeries (both elected and emergency)
Interventions
no intervention
Eligibility Criteria
Patients at surgical ER, and patients in gastrointestinal wards
You may qualify if:
- All patients arriving at surgical emergency and all patients receiving gastrointestinal surgeries in participating centers from 2020.1.1\~2020.3.31.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Beijing Friendship Hospitallead
- Peking University First Hospitalcollaborator
- Peking University People's Hospitalcollaborator
- Peking University Third Hospitalcollaborator
- Chinese PLA General Hospitalcollaborator
- Beijing Hospitalcollaborator
- Xuanwu Hospital, Beijingcollaborator
- Peking Union Medical College Hospitalcollaborator
- Beijing Chao Yang Hospitalcollaborator
- Peking University Cancer Hospital & Institutecollaborator
- China-Japan Friendship Hospitalcollaborator
- Peking University Shougang Hospitalcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhongtao Zhang, M.D.
Beijing Friendship Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 22, 2020
First Posted
May 26, 2020
Study Start
May 25, 2020
Primary Completion
May 31, 2020
Study Completion
June 7, 2020
Last Updated
May 27, 2020
Record last verified: 2020-05